ELISA Kit for Lipopolysaccharide Binding Protein (LBP)
SEB406HU
Product group Assays
Product SEB406HU is not available
Product not available
There may be an alternative product available, please contact our technical support team.
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Lipopolysaccharide Binding Protein (LBP)
- Delivery Days Customer12
- Assay Detection Range3.12-200ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lipopolysaccharide Binding Protein (LBP) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 1.17ng/mL
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Lipopolysaccharide Binding Protein (LBP). Standards or samples are then added to the ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Karow F, Smiljanovic B, Grün JR, et al. Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint. Arthritis Res Ther. 2021,23(1):246. doi: 10.1186/s13075-021-02623-7Read this paper
- Orsso CE, Peng Y, Deehan EC, et al. Composition and Functions of the Gut Microbiome in Pediatric Obesity: Relationships with Markers of Insulin Resistance. Microorganisms. 2021,9(7). doi: 10.3390/microorganisms9071490Read this paper
- Kim H, Kim YJ, Jeong HY, et al. A standardized extract of the fruit of Hovenia dulcis alleviated alcohol-induced hangover in healthy subjects with heterozygous ALDH2: A randomized, controlled, crossover trial. J Ethnopharmacol. 2017,209:167-174. doi: 10.1016/j.jep.2017.07.028Read this paper
- Agiasotelli D, Alexopoulou A, Vasilieva L, et al. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver Int. 2017,37(4):576-582. doi: 10.1111/liv.13264Read this paper
- Kaltsa G, Bamias G, Siakavellas SI, et al. Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis. Ann Gastroenterol. 2016,29(1):63-70.Read this paper
- Upur H, Chen Y, Kamilijiang M, et al. Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study. BMC Complement Altern Med. 2015,15:9. doi: 10.1186/s12906-015-0526-6Read this paper
- Jialal I, Rajamani U, Adams-Huet B, et al. Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity. Atherosclerosis. 2014,236(1):182-7. doi: 10.1016/j.atherosclerosis.2014.06.022Read this paper
- Xiao S, Fei N, Pang X, et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol. 2014,87(2):357-67. doi: 10.1111/1574-6941.12228Read this paper
- Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, et al. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci. 2013,58(10):3029-36. doi: 10.1007/s10620-013-2693-yRead this paper
- Papadopoulos N, Bakhtiary F, Grün V, et al. The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high-risk cardiac surgery patients. Perfusion. 2013,28(4):306-14. doi: 10.1177/0267659113478450Read this paper



